Internal Medicine, Gastroenterology · Lancaster, CA
NPI
1871670091
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
43112 15th St W
Lancaster, CA, 93534
Phone (661) 726-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,061
16 services
Medicare patients, 2024
12
Average age 68
Drug cost, 2024
$154K
1,476 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gurcharn Singh prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 673 prescriptions and refills. In total Gurcharn Singh wrote 1,476 Medicare prescriptions that cost $154K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 673 | 673 | 622 | $15K |
| Pantoprazole Sodium Generic | 258 | 505 | 89 | $3,395 |
| Omeprazole Generic | 119 | 286 | 42 | $1,233 |
| Mesalamine Generic | 63 | 188 | 21 | $27K |
| Budesonide Dr Budesonide | 30 | 37 | Under 11 | $2,529 |
| Nadolol Generic | 30 | 99 | 13 | $972 |
| Adefovir Dipivoxil Generic | 29 | 29 | Under 11 | $17K |
| Azathioprine Generic | 27 | 77 | Under 11 | $1,031 |
| Spironolactone Generic | 22 | 73 | Under 11 | $874 |
| Furosemide Generic | 18 | 57 | Under 11 | $223 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 17 | 17 | Under 11 | $189 |
| Nortriptyline Hcl Generic | 17 | 36 | Under 11 | $370 |
| Lactulose Generic | 16 | 23 | Under 11 | $968 |
| Codeine Sulfate Generic | 12 | 12 | Under 11 | $2,562 |
| Suprep Sodium, Potassium,mag Sulfates | 11 | 11 | 11 | $899 |
Brand drugs: 70 claims; generic drugs: 1,406 claims; opioid claims: 15.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gurcharn Singh were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.